Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK‐1 activation in the NF‐κB and MAPK pathways
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND PURPOSE Kalopanaxsaponin A, a triterpenoid saponin isolated from Kalopanax pictus (family Araliaceae), potently inhibited nuclear factor‐kappa B (NF‐κB) activation in lipopolysaccharide (LPS)‐stimulated peritoneal macrophages during a screening programme for anti‐colitis agents from natural products. Its anti‐inflammatory mechanism remains unknown. Therefore, we investigated its anti‐inflammatory effects in lipopolysaccharide (LPS)‐ or peptidoglycan‐stimulated murine peritoneal macrophages and trinitrobenzene sulphonic acid (TNBS)‐induced colitic mice. EXPERIMENTAL APPROACH Peritoneal macrophages from male ICR mice were stimulated with LPS or peptidoglycan in vitro and treated with kalopanaxsaponin A. Colitis was induced in vivo by intrarectal administration of TNBS in male ICR mice. Mice were treated daily with kalopanaxsaponin A, sulphasalazine or phosphate‐buffered saline. Inflammatory markers, cytokines, enzymes and transcription factors were measured by ELISA, immunoblot, flow cytometry and immunofluorescent confocal microscopy. KEY RESULTS Kalopanaxsaponin A potently inhibited the expression of the pro‐inflammatory cytokines, interleukin (IL)‐1β, tumour necrosis factor (TNF)‐α and IL‐6, induced by LPS, but not that induced by TNF‐α, in peritoneal macrophages. However, it potently increased the expression of the anti‐inflammatory cytokine IL‐10. Kalopanaxsaponin A inhibited activation of the IL‐1 receptor‐associated kinase (IRAK)‐1, inhibitor of κB kinase‐β, NF‐κB and mitogen‐activated protein kinases (extracellular signal‐regulated kinase, c‐Jun NH 2‐terminal kinase, p‐38), but LPS/Toll‐like receptor‐4 interaction and IRAK‐4 activation were not affected. Oral administration of kalopanaxsaponin A (10 and 20 mg·kg−1) improved the clinical parameters and histology in vivo. Kalopanaxsaponin A inhibited NF‐κB and mitogen‐activated protein kinase activation induced by TNBS by suppressing IRAK‐1 activation. CONCLUSIONS AND IMPLICATIONS Kalopanaxsaponin A may improve inflammatory diseases, such as colitis, by inhibiting IRAK‐1 activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918 · cited 1×
“Inflammatory diseases involve over-expression of pro-inflammatory cytokines, such as TNF-a, IL-1b and IL-6, and inflammatory mediators, such as NO and PGE2, via NF-kB and MAPK pathways in macrophages (Moynagh, 2005; Tak and Firestein, 2001).”
BackgroundTAK1 is a ubiquitin-dependent kinase of MKK and IKK
Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J.-I., & Chen, Z. J. (2001) · Nature · doi:10.1038/35085597 · Cited by 2,125
Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2
Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., & Kirschning, C. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17406 · Cited by 1,704 · cited 1×
“…kinases (IRAKs), TLR4 may serve as the main mediator of lipopolysaccharide (LPS) signalling in IBD (Ingalls et al., 1999; Cario and Podolsky, 2000) while TLR2 recognizes lipoproteins and lipopeptides from Gram-positive bacteria, mycoplasma and mycobacteria (Schwandner et al., 1999).”
BackgroundEffects of a Combination of Thyme and Oregano Essential Oils on TNBS-Induced Colitis in Mice
Bukovská, A., Cikoš, Š., Juhás, Š., Il’ková, G., Rehák, P., & Koppel, J. (2007) · Mediators of Inflammation · doi:10.1155/2007/23296 · Cited by 125
Cited by
Kim, K.-A., Gu, W., Lee, I.-A., Joh, E.-H., & Kim, D.-H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047713 · Cited by 1,176
Self-citationGut microbiota lipopolysaccharide accelerates inflamm-aging in mice
Kim, K.-A., Jeong, J.-J., Yoo, S.-Y., & Kim, D.-H. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0625-7 · Cited by 196
Self-citationMacrophage-based nanotherapeutic strategies in ulcerative colitis
Zhang, J., Zhao, Y., Hou, T., Zeng, H., Kalambhe, D., Wang, B., Shen, X., & Huang, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.047 · Cited by 160
Jeong, J.-J., Kim, K.-A., Jang, S.-E., Woo, J.-Y., Han, M. J., & Kim, D.-H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116533 · Cited by 86
“1 mMH2O2 and incubated at 37°C; the absorbance was obtained at 650 nm over time [25].”
MethodInfluentialSelf-citationMangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-κB and MAPK pathways
Jeong, J.-J., Jang, S.-E., Hyam, S. R., Han, M. J., & Kim, D.-H. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.06.013 · Cited by 78
Self-citation
Metadata
- Authors
- Joh, E., & Kim, D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-03-22
- Volume
- 162
- Issue
- 8
- Pages
- 1731-1742
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1586434302
- Cited by
- 57
- References
- 4
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK‐1 activation in the NF‐κB and MAPK pathways. https://app.cochat.ai/papers/10.1111/j.1476-5381.2010.01195.x
- The paper
- Joh, E., & Kim, D. (2011). Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK‐1 activation in the NF‐κB and MAPK pathways. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2010.01195.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.